Later-Line Treatment with Lorlatinib in

ALK tyrosine kinase inhibitor treatment ALK-positive disease ROS1-positive disease lorlatinib sequential treatment

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
07 Nov 2020
Historique:
received: 22 09 2020
revised: 20 10 2020
accepted: 05 11 2020
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 12 11 2020
Statut: epublish

Résumé

In clinical practice, patients with

Identifiants

pubmed: 33171712
pii: ph13110371
doi: 10.3390/ph13110371
pmc: PMC7694976
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Thorac Oncol. 2020 Sep;15(9):1484-1496
pubmed: 32360579
Neoplasia. 2008 Mar;10(3):298-302
pubmed: 18320074
N Engl J Med. 2014 Mar 27;370(13):1189-97
pubmed: 24670165
Acta Pharm Sin B. 2015 Jan;5(1):34-7
pubmed: 26579422
Cancer Sci. 2008 Dec;99(12):2349-55
pubmed: 19032370
Ann Oncol. 2019 May;30(5):863-870
pubmed: 31987360
Mol Cancer Ther. 2014 Dec;13(12):2910-8
pubmed: 25349307
Nature. 2007 Aug 2;448(7153):561-6
pubmed: 17625570
Cancer Discov. 2016 Oct;6(10):1118-1133
pubmed: 27432227
Cancer Cell. 2015 Jul 13;28(1):70-81
pubmed: 26144315
Clin Cancer Res. 2015 Jun 15;21(12):2745-52
pubmed: 25724526
Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S265-S279
pubmed: 31857950
Clin Cancer Res. 2015 May 15;21(10):2227-35
pubmed: 25979929
Clin Cancer Res. 2016 Nov 15;22(22):5527-5538
pubmed: 27780853
Clin Cancer Res. 2017 Jan 1;23(1):204-213
pubmed: 27370605
Clin Cancer Res. 2008 Jul 1;14(13):4275-83
pubmed: 18594010
Clin Transl Oncol. 2020 Mar;22(3):294-301
pubmed: 31630357
J Med Chem. 2019 Nov 27;62(22):10272-10293
pubmed: 31689114
Eur J Med Chem. 2017 Jul 7;134:348-356
pubmed: 28431340
Onco Targets Ther. 2014 Mar 05;7:375-85
pubmed: 24623980
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3493-8
pubmed: 25733882
Lancet Oncol. 2018 Dec;19(12):1654-1667
pubmed: 30413378
Clin Cancer Res. 2008 Oct 15;14(20):6618-24
pubmed: 18927303
Cancer. 2009 Apr 15;115(8):1723-33
pubmed: 19170230
Lung Cancer. 2020 Jun;144:10-19
pubmed: 32344248
J Med Chem. 2019 Aug 8;62(15):6843-6853
pubmed: 30860377
J Mol Diagn. 2018 Mar;20(2):129-159
pubmed: 29398453

Auteurs

Maximilian J Hochmair (MJ)

Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Hannah Fabikan (H)

Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Oliver Illini (O)

Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Christoph Weinlinger (C)

Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Ulrike Setinek (U)

Institute of Pathology and Clinical Microbiology, Wilhelminenspital, Montleartstrasse 37, 1160 Vienna, Austria.

Dagmar Krenbek (D)

Institute of Pathology and Clinical Microbiology, Wilhelminenspital, Montleartstrasse 37, 1160 Vienna, Austria.
Department of Pathology and Bacteriology, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Helmut Prosch (H)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Währingergürtel 18-22, 1090 Vienna, Austria.

Markus Rauter (M)

Clinic of Pneumology, Klinikum Klagenfurt am Wörthersee, Feschnigstrasse 11, 9020 Klagenfurt am Wörthersee, Austria.

Michael Schumacher (M)

Ordensklinikum Linz Elisabethinen, Fadingerstrasse 1, 4020 Linz, Austria.

Ewald Wöll (E)

St. Vinzenz Krankenhaus Betriebs GmbH, Klostergasse 10, 6511 Zams, Austria.

Romana Wass (R)

Department of Pneumology, Johannes Kepler University Linz, Krankenhausstrasse 26-30/Med Campus IV, 4020 Linz, Austria.
Department of Pneumology, Paracelsus Medical University, SALK, Müllner Hauptstrasse 46, 5020 Salzburg, Austria.

Elmar Brehm (E)

Department of Pneumology, Johannes Kepler University Linz, Krankenhausstrasse 26-30/Med Campus IV, 4020 Linz, Austria.

Gudrun Absenger (G)

Department of Oncology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

Tatjana Bundalo (T)

Landesklinikum Hochegg, Hocheggerstrasse 88, 2840 Hochegg, Austria.

Peter Errhalt (P)

Clinical Department of Pneumology, University Hospital Krems, Mitterweg 10, 3500 Krems, Austria.

Matthias Urban (M)

Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Arschang Valipour (A)

Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Brünner Strasse 68, 1210 Vienna, Austria.

Classifications MeSH